Today's Pre-Market Trading Very Positive For Mallinckrodt (MNK)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Mallinckrodt ( MNK) as a pre-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Mallinckrodt as such a stock due to the following factors:

  • MNK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $203.3 million.
  • MNK traded 10,589 shares today in the pre-market hours as of 8:01 AM.
  • MNK is up 4.3% today from Friday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MNK with the Ticky from Trade-Ideas. See the FREE profile for MNK NOW at Trade-Ideas

More details on MNK:

Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical products and medical imaging agents worldwide. The company operates through two segments, Specialty Pharmaceuticals and Global Medical Imaging. Currently there are 8 analysts that rate Mallinckrodt a buy, no analysts rate it a sell, and 2 rate it a hold.

The average volume for Mallinckrodt has been 1.3 million shares per day over the past 30 days. Mallinckrodt has a market cap of $13.2 billion and is part of the health care sector and drugs industry. Shares are up 15.3% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

The Stock Market Gets Smashed -- Here Are Some Terrible Performers

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Earnings Are Back With a Vengeance: Cramer's 'Mad Money' Recap (Monday 7/24/17)